兴齐眼药(300573.SZ)：盐酸奥布卡因滴眼液获药品注册证书

Core Viewpoint - The company has received approval from the National Medical Products Administration for its drug, Oubakain Hydrochloride Eye Drops, which is intended for surface anesthesia in ophthalmology [1] Company Summary - The approved product is a single-dose formulation that does not contain preservatives [1] - The active ingredient in the eye drops is Oubakain Hydrochloride [1] - This approval marks a significant milestone for the company in expanding its product offerings in the ophthalmic field [1]